Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

N/ANon-phased studies

2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials

Showing 3 of 3

completednot_applicable

Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) Study

NCT00745043

completed

The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children

NCT02743663

completednot_applicable

Airway Inflammation in Congenital Diaphragmatic Hernia Patients

NCT02453750

Clinical Trials (3)

Showing 3 of 3 trials

NCT00745043Not Applicable

Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) Study

Completed

NCT02743663

The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children

Completed

NCT02453750Not Applicable

Airway Inflammation in Congenital Diaphragmatic Hernia Patients

Completed

All 3 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 3